Literature DB >> 16207566

Management of the hematologic complications of hepatitis C therapy.

Mark S Sulkowski1.   

Abstract

Consensus guidelines are in place for treating chronic hepatitis C virus infection. This article highlights some of the hematologic complications of hepatitis C therapy. Management options are presented.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16207566     DOI： 10.1016/j.cld.2005.07.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  9 in total

1.  The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.

Authors:  Tarek Hassanein; Mitchell L Shiffman; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

2.  Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve 'real-life' patients in India.

Authors:  Ajit Sood; Vandana Midha; Omesh Goyal; Syed Hissar; Suresh Kumar Sharma; Pankaj Khanna
Journal:  Indian J Gastroenterol       Date:  2014-03-12

3.  Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.

Authors:  M Palmer; R Rubin; V Rustgi
Journal:  Aliment Pharmacol Ther       Date:  2012-06-19       Impact factor: 8.171

4.  Pathobiology and treatment of hepatitis virus-related thrombocytopenia.

Authors:  Roberto Stasi; Lian Wea Chia; Pallavi Kalkur; Robert Lowe; Muriel S Shannon
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-25       Impact factor: 2.576

5.  Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection.

Authors:  Malgorzata Pawlowska; Malgorzata Pilarczyk; Anna Foksinska; Ewa Smukalska; Waldemar Halota
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

Review 6.  Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection.

Authors:  Shiksha Kedia; Vijaya Raj Bhatt; Sandeep Kumar Rajan; Pavan Kumar Tandra; Radwa A El Behery; Mojtaba Akhtari
Journal:  Int J Prev Med       Date:  2014-12

Review 7.  Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Sumit Dahal; Smrity Upadhyay; Rashmi Banjade; Prajwal Dhakal; Nabin Khanal; Vijaya Raj Bhatt
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

8.  Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.

Authors:  Nuntra Suwantarat; Alan D Tice; Thana Khawcharoenporn; Dominic C Chow
Journal:  Int J Med Sci       Date:  2010-01-22       Impact factor: 3.738

Review 9.  The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.

Authors:  Fazal-I-Akbar Danish; Saeeda Yasmin
Journal:  Hepat Med       Date:  2013-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.